Cohen & Steers’s VanEck Pharmaceutical ETF PPH Stock Holding History

Cohen & Steers’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,248	Closed	-$385K	–	460
2024 Q1	$385K	Hold	4,248	–	–	﹤0.01%	296
2023 Q4	$346K	Sell	4,248 -7,500	-64%	-$588K	﹤0.01%	296
2023 Q3	$938K	Hold	11,748	–	–	﹤0.01%	247
2023 Q2	$925K	Hold	11,748	–	–	﹤0.01%	262
2023 Q1	$912K	Hold	11,748	–	–	﹤0.01%	258
2022 Q4	$913K	Hold	11,748	–	–	﹤0.01%	268
2022 Q3	$790K	Buy	11,748 +1,893	+19%	+$139K	﹤0.01%	269
2022 Q2	$757K	Buy	+9,855	New	+$769K	﹤0.01%	271

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

FPGK

Financial Partners Group (Kansas) Overland Park, Kansas $836M AUM 21.04% 1-Year Est. Return

Cohen & Steers's PPH Position: Q2 2024 in Review

Cohen & Steers sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2024, closing a stake of 4,248 shares — an estimated $385K sold.

Cohen & Steers first reported a position in PPH in Q2 2022 and held it in 8 quarters. The position peaked at $938K in Q3 2023. 140 funds tracked by Wall St. Rank hold PPH as of Q2 2024.

Cohen & Steers reported no remaining VanEck Pharmaceutical ETF position as of Q2 2024 after selling out during the quarter.
Cohen & Steers sold 4,248 VanEck Pharmaceutical ETF shares in Q2 2024, an estimated $385K.
Cohen & Steers first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and held it in 8 quarters.
Cohen & Steers's VanEck Pharmaceutical ETF position peaked at $938K in Q3 2023.
140 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2024.

Based on Cohen & Steers's 13F filing for Q2 2024, filed 13 Aug 2024.